Production (Stage)
Utah Medical Products, Inc.
UTMD
$53.76
$0.100.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.04M | 2.90M | 3.56M | 3.45M | 3.96M |
| Total Depreciation and Amortization | 721.00K | 730.00K | 740.00K | 693.00K | 683.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -136.00K | 133.00K | 0.00 | -107.00K | -112.00K |
| Change in Net Operating Assets | 838.00K | -828.00K | -447.00K | -1.28M | 749.00K |
| Cash from Operations | 4.46M | 2.94M | 3.86M | 2.76M | 5.28M |
| Capital Expenditure | -184.00K | -9.00K | -89.00K | -110.00K | -22.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 27.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | -5.00K | -- |
| Cash from Investing | -184.00K | -9.00K | -89.00K | -115.00K | 5.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 0.00 | 294.00K | 96.00K |
| Repurchase of Common Stock | -3.22M | -6.71M | -3.87M | -6.40M | -2.99M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.02M | -1.04M | -1.05M | -1.08M | -1.09M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.24M | -7.75M | -4.92M | -7.19M | -3.98M |
| Foreign Exchange rate Adjustments | 307.00K | -657.00K | 384.00K | -46.00K | -358.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 349.00K | -5.48M | -767.00K | -4.59M | 940.00K |